Cargando…
Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Compuscript
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618949/ https://www.ncbi.nlm.nih.gov/pubmed/37823691 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0286 |
| _version_ | 1785129885853810688 |
|---|---|
| author | Dai, Lei-Jie Li, Yu-Wei Ma, Ding Shao, Zhi-Ming Jiang, Yi-Zhou |
| author_facet | Dai, Lei-Jie Li, Yu-Wei Ma, Ding Shao, Zhi-Ming Jiang, Yi-Zhou |
| author_sort | Dai, Lei-Jie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10618949 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Compuscript |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106189492023-11-02 Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer Dai, Lei-Jie Li, Yu-Wei Ma, Ding Shao, Zhi-Ming Jiang, Yi-Zhou Cancer Biol Med Editorial Compuscript 2023-10-15 2023-10-12 /pmc/articles/PMC10618949/ /pubmed/37823691 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0286 Text en Copyright: © 2023, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Dai, Lei-Jie Li, Yu-Wei Ma, Ding Shao, Zhi-Ming Jiang, Yi-Zhou Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer |
| title | Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer |
| title_full | Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer |
| title_fullStr | Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer |
| title_full_unstemmed | Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer |
| title_short | Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer |
| title_sort | next-generation antibody–drug conjugates revolutionize the precise classification and treatment of her2-expressing breast cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618949/ https://www.ncbi.nlm.nih.gov/pubmed/37823691 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0286 |
| work_keys_str_mv | AT daileijie nextgenerationantibodydrugconjugatesrevolutionizethepreciseclassificationandtreatmentofher2expressingbreastcancer AT liyuwei nextgenerationantibodydrugconjugatesrevolutionizethepreciseclassificationandtreatmentofher2expressingbreastcancer AT mading nextgenerationantibodydrugconjugatesrevolutionizethepreciseclassificationandtreatmentofher2expressingbreastcancer AT shaozhiming nextgenerationantibodydrugconjugatesrevolutionizethepreciseclassificationandtreatmentofher2expressingbreastcancer AT jiangyizhou nextgenerationantibodydrugconjugatesrevolutionizethepreciseclassificationandtreatmentofher2expressingbreastcancer |